← All indications
Immunosuppression Therapy
Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs.
Subtype terms (4)
More specific conditions that are subtypes of Immunosuppression Therapy in the MeSH hierarchy.
Drugs by status
Phase 4 trials (29)
- 23-valent pneumococcal polysaccharide vaccine
- methylprednisolone
- sucrose
- lipopolysaccharide
- daclizumab
- prednisone
- tacrolimus
- esketamine
- pitavastatin
- atorvastatin
- sirolimus
- cyclosporine
- mycophenolate
- cyclophosphamide
- everolimus
- tocilizumab
- pantoprazole
- Anti-thymocyte Globulin (Rabbit)
- infliximab
- methotrexate
- virosomal influenza vaccine
- rituximab
- tenofovir alafenamide
- azathioprine
- anakinra
- quinapril
- dexamethasone
- 15-valent pneumococcal conjugate vaccine
- bnt162b2
Phase 3 trials (6)
Phase 2 trials (10)
Phase 1 trials (10)